Skip to main content
← All data ties

Drug Use And Addiction Research in Rhode Island

$125,381,038.78 is the USAspending.gov obligation total for Drug Use And Addiction Research Programs (CFDA 93.279) with place of performance in Rhode Island. The source table counts 105 awards. The pair is not a patient census, a trial roster, or a named-investigator list. Dividing those two facts yields about $1,194,105.13 per award. Figures are obligations, not outlays.

Key figures

  • CFDA 93.279 shows $125,381,038.78 in Rhode Island obligations on 105 awards.
  • The mean is about $1,194,105.13 per award.
  • The catalog is Drug Use And Addiction Research Programs, not a patient census, a trial roster, or a named-investigator list.
  • Rhode Island is a place-of-performance tag, not a unit census.
  • Figures are obligations, not outlays.

What the 93.279–Rhode Island join records

This page exists because two tables meet: Drug Use And Addiction Research Programs (CFDA 93.279) and Rhode Island (RI). USAspending.gov records $125,381,038.78 on 105 awards at that intersection. Correlation is not causation: Rhode Island did not cause $125,381,038.78 by existing as a large or small place. FEC donations do not fund this USAspending cell.

Drug Use And Addiction Research Programs in Rhode Island applies both keys. CFDA 93.279 is CFDA 93.279 without a Rhode Island filter. Rhode Island federal spending is all-program Rhode Island spending. Rhode Island programs lists other Rhode Island programs. All spending ties indexes other joins. Correlation is not causation: Rhode Island did not cause $125,381,038.78 by existing as a large or small place.

Addiction research as a listing, not a trial registry

CFDA 93.279 is DRUG USE AND ADDICTION RESEARCH PROGRAMS. Packet facts on the program side stop at the name Drug Use And Addiction Research Programs, the number 93.279, $125,381,038.78, and 105 awards. This packet lists no award recipients and no contractor names. Mixing this listing with other health-research catalog lines that use different CFDA numbers would invent a combined total the packet never computed. DRUG USE AND ADDICTION RESEARCH PROGRAMS is the catalog title. One hundred five awards is a multi-project extramural file: research assistance often posts as about a hundred discrete records. The join does not convert dollars into labs, trials, or patients. Neighbor-state Addiction research joins are other pairs.

Drug Use And Addiction Research Programs is not cardiovascular research and not a treatment-services twin. One hundred five records against $125,381,038.78 do not name investigators. This page is not medical advice. A 93.279 award tagged to Massachusetts stays outside this Rhode Island cell. Quote CFDA 93.279 and Rhode Island together.

Rhode Island place of performance on 93.279

Place of performance in Rhode Island is a USAspending geography field. Providence, Warwick, or Newport folklore may send a reader here; those stories are not a metro split in this packet. Awards can list RI while later work occurs elsewhere. Neighbor codes (Massachusetts and Connecticut) stay outside $125,381,038.78. Place of performance can differ from where a recipient is headquartered. This packet does not publish either split. Neighbor-state Addiction research joins are other pairs, not addends.

One hundred five awards, not 105 named labs

105 is the award-record count. It is not 105 labs, trials, or patients. A mean of about $1,194,105.13 if $125,381,038.78 were divided evenly across 105 lines is arithmetic, not a typical payment. Unique vendors are unpublished. Treat one hundred five as a record count, not a unit census. A later USAspending ingest can restate both $125,381,038.78 and the 105-award count without changing the join keys. Agency splits are omitted from this packet. No fiscal year is in the facts, so none is cited here.

What addiction research in Rhode Island will not prove

Keep $125,381,038.78 labeled as obligations. Outlays, remaining balances, and recipient names are unpublished. The join is not a patient census, a trial roster, or a named-investigator list. Quote Drug Use And Addiction Research Programs and Rhode Island together. Later bulk files can move both the dollars and the 105-award count. Campaign-finance tables do not fund these USAspending obligations. Unique recipients remain unpublished on this Drug Use And Addiction Research Programs Rhode Island join.

Use /states/ri/programs/93.279/ (Drug Use And Addiction Research Programs in Rhode Island) for the overlay, /programs/93.279/ (CFDA 93.279) for the listing, /states/ri/ (Rhode Island federal spending) for the state hub, /states/ri/programs/ (Rhode Island programs) for the program index, and /ties/ (All spending ties) for other pairs. Cite CFDA 93.279, Rhode Island, $125,381,038.78, USAspending.gov, obligations only. Keep Drug Use And Addiction Research Programs and Rhode Island together when citing $125,381,038.78. CFDA 93.279 lists 105 award records on this RI join. Obligations of $125,381,038.78 are not outlays. Original filings remain on USAspending.gov for this CFDA 93.279 × RI pair. Do not add parent hubs into this state-program cell. Quote CFDA 93.279, Rhode Island, and $125,381,038.78 in one sentence. The Rhode Island programs index and All spending ties index are larger than this cell. This page is not a patient census, a trial roster, or a named-investigator list. 105 award records are not 105 labs, trials, or patients. Mean dollars per action remain about $1,194,105.13 if you divide those two facts. RI is place of performance, not a split of Providence, Warwick, or Newport. Drug Use And Addiction Research Programs is not cardiovascular research and not a treatment-services twin. One hundred five records against $125,381,038.78 do not name investigators. This page is not medical advice. A 93.279 award tagged to Massachusetts stays outside this Rhode Island cell. Quote CFDA 93.279 and Rhode Island together. Source note: USAspending.gov CFDA program aggregates by place of performance state. Obligations are not outlays.

Questions

How much Addiction research funding is obligated in Rhode Island?
USAspending.gov records $125,381,038.78 in CFDA 93.279 obligations with Rhode Island place of performance on 105 awards. That is the pair total, not an outlay and not a patient census, a trial roster, or a named-investigator list. Keep Drug Use And Addiction Research Programs and Rhode Island together when citing $125,381,038.78.
Do 105 awards mean 105 Rhode Island laboratories?
No. 105 is a USAspending award-record count, not 105 labs, trials, or patients. The implied mean is about $1,194,105.13 per award. Unique recipients are unpublished. Obligations of $125,381,038.78 are not outlays. USAspending.gov remains the source for this 93.279 × RI pair.
Is this Rhode Island’s full federal health-research spend?
No. $125,381,038.78 is only the CFDA 93.279 × Rhode Island cell. Other catalogs appear on separate Rhode Island program pages. Nationwide 93.279 is not limited to Rhode Island. Mixing this listing with other health-research catalog lines that use different CFDA numbers would invent a larger total.
Where is the live 93.279 × Rhode Island table?
Drug Use And Addiction Research Programs in Rhode Island is the overlay at /states/ri/programs/93.279/. CFDA 93.279 is /programs/93.279/. Rhode Island federal spending is /states/ri/. Rhode Island programs is /states/ri/programs/. All spending ties is /ties/. Original filings remain on USAspending.gov for this 93.279 × RI pair.

USAspending.gov CFDA program aggregates by place of performance state. Obligations are not outlays.